|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Alcon Research |
|---|---|
| Information provided by: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT00047606 |
Purpose
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.
| Condition | Intervention | Phase |
|---|---|---|
|
Open-Angle Glaucoma Ocular Hypertension |
Drug: IOP Lowering Medications |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | Phase 4 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Caucasian and Japanese Subjects C-02-32. |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Adults of Caucasian and Japanese Ethnicity
Contacts and Locations
More Information
| ClinicalTrials.gov Identifier: | NCT00047606 History of Changes |
| Other Study ID Numbers: | C-02-32, C-02-32 |
| Study First Received: | October 8, 2002 |
| Last Updated: | August 4, 2008 |
| Health Authority: | United States: Food and Drug Administration |
|
open-angle glaucoma ocular hypertension |
POAG Iris Pigmentation Japanese |
|
Glaucoma Glaucoma, Open-Angle Hypertension Ocular Hypertension |
Eye Diseases Vascular Diseases Cardiovascular Diseases |